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Abstract
Background: The association of specific bioactive flavonoids and terpenoids with fluoride can
modulate the development of cariogenic biofilms by simultaneously affecting the synthesis of
exopolysaccharides (EPS) and acid production by Streptococcus mutans, which enhanced the
cariostatic effectiveness of fluoride in vivo. In the present study, we further investigated whether
the biological actions of combinations of myricetin (flavonoid), tt-farnesol (terpenoid) and fluoride
can influence the expression of specific genes of S. mutans within biofilms and their structural
organization using real-time PCR and confocal fluorescence microscopy.
Results: Twice-daily treatment (one-minute exposure) during biofilm formation affected the gene
expression by S. mutans both at early (49-h) and later (97-h) stages of biofilm development. Biofilms
treated with combination of agents displayed lower mRNA levels for gtfB and gtfD (associated with
exopolysaccharides synthesis) and aguD (associated with S. mutans acid tolerance) than those
treated with vehicle-control (p  < 0.05). Furthermore, treatment with combination of agents
markedly affected the structure-architecture of S. mutans biofilms by reducing the biovolume
(biomass) and proportions of both EPS and bacterial cells across the biofilm depth, especially in the
middle and outer layers (vs. vehicle-control, p < 0.05). The biofilms treated with combination of
agents were also less acidogenic, and had reduced amounts of extracellular insoluble glucans and
intracellular polysaccharides than vehicle-treated biofilms (p < 0.05).
Conclusion: The data show that the combination of naturally-occurring agents with fluoride
effectively disrupted the expression of specific virulence genes, structural organization and
accumulation of S. mutans biofilms, which may explain the enhanced cariostatic effect of our
chemotherapeutic approach.
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Background
Oral diseases related to dental biofilms, such as dental car-
ies, continue to afflict the majority of the World's popula-
tion [1]. This ubiquitous disease results from the
interaction of specific bacteria with constituents of the
diet within a biofilm known as plaque. Streptococcus
mutans effectively colonizes tooth surfaces, and is a key
contributor to the formation of cariogenic biofilms
because this bacterium (i) utilizes dietary sucrose to syn-
thesize large amounts of extracellular polysaccharides
(EPS), (ii) adheres tenaciously to glucan-coated surfaces,
and (iii) is also highly acidogenic and acid-tolerant [2,3].
The majority of biofilm matrices are rich in polysaccha-
rides, and dental biofilms are no exception. Polysaccha-
rides of dental biofilms are mostly glucans synthesized by
microbial glycosyltransferases (Gtfs), which are largely
insoluble and complex in structure [4,5]. The Gtfs secreted
by S. mutans (particularly GtfB and GtfC) bind to the
tooth surface and to surfaces of bacteria [6-8]. The glucans
synthesized by surface-adsorbed Gtfs provide specific
binding sites for bacterial colonization on the tooth sur-
face and to each other; thus, contributing to the initial
steps of cariogenic biofilm development [3,8]. If the bio-
film is allowed to remain on tooth surfaces and is exposed
to dietary carbohydrates frequently (especially sucrose), S.
mutans as a constituent of the biofilm community will
continue to synthesize polysaccharides and metabolize
the sugars to organic acids. The elevated amounts of EPS,
which may involve up-regulation of gtf genes in response
to pH and carbohydrate availability [9], increase the bio-
films bulk and stability, and enhance its virulence [1,3]. In
addition, the ability of S. mutans to utilize some extra- and
intracellular polysaccharides as short-term storage com-
pounds offers an additional ecological benefit, and simul-
taneously, increases the amount of acid production and
the extent of acidification. The persistence of this aciduric
environment leads to selection of highly acid tolerant
(and acidogenic) flora [1,2,10]; the low pH environment
within the biofilm's matrix results in dissolution of
enamel, thus initiating the pathogenesis of dental caries.
Clearly, EPS (e.g. glucans) and acidification of the matrix
by S. mutans (and other acidogenic and aciduric organ-
isms) could be primary targets for chemotherapeutic
intervention to prevent the formation of cariogenic bio-
films.
Strategies of controlling biofilm aimed at disrupting bac-
terial virulence offer an attractive and alternative
approach to the traditional antimicrobial therapy based
on use of broad spectrum microbiocides [11]. We have
followed a novel combination therapy using specific nat-
urally occurring compounds and fluoride aiming at dis-
rupting EPS-matrix formation and acidogenicity of S.
mutans within biofilms [12,13]. The strategy is based on
their interconnected biological activities; the bioflavo-
noids (e.g. apigenin or myricetin) are potent inhibitors of
glucan synthesis by Gtf enzymes [12,14] whereas the ter-
penoids(e.g. tt-farnesol) and fluoride disrupts the proton
permeability of S. mutans membrane, affecting its glyco-
lytic activity, production-secretion of Gtfs and acidurance
[10,15,16]; fluoride, of course, has additional physico-
chemical effects [17,18]. The combination of natural
agents with 250 ppm fluoride resulted in enhanced cario-
static properties of fluoride in vivo, without suppressing
the resident oral flora [12,13].
In this study, we further investigated whether the biologi-
cal actions of the combination of agents can influence the
expression of specific genes of Streptococcus mutans during
biofilm formation, and the spatial distribution of bacte-
rial cells and exopolysaccharides in the biofilm's matrix.
Methods
Test compounds
Myricetin was obtained from Extrasynthese Co. (Genay-
Sedex, France). tt-Farnesol and sodium fluoride were pur-
chased from Sigma-Aldrich Co. (St Louis, MO). For this
study, we tested 1.0 mM myricetin and 2.5 mM tt-farnesol
in combination with sodium fluoride (125 ppm F or 250
ppm F). The concentrations of the natural agents were
selected based on data from our previously published and
unpublished response to dose studies [13,19,20]. Fluo-
ride at 225-250 ppm is a clinically proven anticaries agent,
and is the concentration found in most of the currently
commercially available fluoride-based mouth rinses as
reviewed in Marinho et al. [17] and Zero [18]. The test
agents, including fluoride, were dissolved in 20% ethanol
containing 2.5% dimethyl sulphoxide (DMSO) just prior
to carrying out the assays.
Biofilm preparation and treatments
Biofilms of S. mutans UA159 were formed on saliva-
coated hydroxyapatite (sHA) discs (surface area of 2.93 ±
0.2 cm2, Clarkson Chromatography Products Inc., South
Williamsport, PA, USA) in batch cultures for 5 days, as
detailed elsewhere [21]. The biofilms were grown in ultra-
filtered (10 kDa molecular-weight cut-off) buffered tryp-
tone yeast-extract broth containing 1% (w/v) sucrose [21].
The culture medium was replaced daily; the organisms
were grown undisturbed for 22 h to allow initial biofilm
formation. At this point (22 h old), the biofilms were then
treated twice-daily (at 10 a.m. and 4 p.m.) until the end of
the experimental period (118-h-old biofilm) with one of
the following: (i) 1.0 mM myricetin + 2.5 mM tt-farnesol
+ 125 ppm fluoride (MFar125F); (ii) 1.0 mM myricetin +
2.5 mM tt-farnesol + 250 ppm fluoride (MFar250F); (iii)
250 ppm fluoride (250F); (iv) vehicle control (20% etha-BMC Microbiology 2009, 9:228 http://www.biomedcentral.com/1471-2180/9/228
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nol containing 2.5% DMSO in water); fluoride at 125
ppm F was not included because it is devoid of any signif-
icant anti-biofilm effects [12,13]. The biofilms were
exposed to the treatments for 1 min., dip-rinsed three
times in sterile saline solution (to remove excess of agents
or vehicle-control) and transferred to culture medium.
The treatments and rinsing procedures were repeated 6 h
later. The pH of culture medium surrounding the biofilms
was also determined during the experimental period
(until 118 hour biofilms, at 8 a.m., 12 a.m., 4 p.m., 6
p.m.). Our previous studies have shown that the vehicle
control (1 min exposure, twice daily) allowed the contin-
ued formation of biofilm, and did not affect the biochem-
ical composition and cell viability when compared to
biofilms treated with saline solution [20,21]. Each bio-
film was exposed to the respective treatment a total of 8
times. Biofilm assays were performed in duplicate in at
least six different experiments.
RNA extraction and real-time RT-PCR
At selected time points (49- and 97-h-old biofilms), RNA
was extracted and purified using standard protocols opti-
mized for biofilms [22]; RNA integrity number (RIN) for
our samples was ≥ 9.0 as determined by lab on-chip cap-
illary electrophoresis [22]. The reverse transcriptase PCR,
real-time qPCR amplification conditions, and the gene-
specific primers (for gtfB, gtfC and gtfD) were similar to
those described previously [14]. Specific genes related to
acid tolerance mechanisms, aguD (part of the agmatine
deiminase system operon) and atpD (part of the F-ATPase
operon) were also tested. The aguD (5- ATCCCGTGAGT-
GATAGTATTTG -3 and 5-CAAGCCACCAACAAGTAAGG-
3) and atpD (5-CGTGCTCTCTCGCCTGAAATAG-3 and 5-
ACTCACGATAACGCTGCAAGAC-3) specific primers
were designed using Beacon Designer 2.0 software (Pre-
mier Biosoft International, Palo Alto, CA, USA). Briefly,
cDNAs were synthesized using BioRad iScript cDNA syn-
thesis kit (Bio-Rad Laboratories, Inc., CA). To check for
DNA contamination, purified total RNA without reverse
transcriptase served as a negative control. The resulting
cDNA and negative controls were amplified by a MyiQ
real-time PCR detection system with iQ SYBR Green
supermix (Bio-Rad Laboratories, Inc., CA, USA) and spe-
cific primers. A standard curve was plotted for each primer
set as detailed elsewhere [14]. The standard curves were
used to transform the critical threshold cycle (Ct) values
to the relative number of cDNA molecules. Relative
expression was calculated by normalizing each gene of
interest of the treated biofilms to the 16SrRNA gene,
which served as the reference gene [14]. These values were
then compared to those from biofilms treated with vehi-
cle-control to determine the change in gene expression
[14]. The number of copies of 16SrRNA in the biofilms
treated with test agents and vehicle control was not signif-
icantly different from each other (P > 0.05).
Laser scanning confocal fluorescence microscopy imaging 
of biofilms
At the end of the experimental period (118-h-old bio-
films), the structural organization of the biofilms was
examined by simultaneous in situ labeling of extracellular
polysaccharides (EPS) and bacterial cells as described by
Klein  et al. [23]. Briefly, 2.5 μM of Alexa Fluor® 647-
labeled dextran conjugate (10,000 MW; absorbance/fluo-
rescence emission maxima 647/668 nm; Molecular
Probes Inc., Eugene, OR) were added to the culture
medium during the formation and development of S.
mutans biofilms. The fluorescence-labeled dextran serves
as a primer for Gtfs and can be simultaneously incorpo-
rated during the extracellular polysaccharide matrix syn-
thesis over the course of the biofilm development, but
does not stain the bacterial cells at concentrations used in
this study [23]. The bacterial cells in biofilms were labeled
by means of 2.5 μM of SYTO® 9 green-fluorescent nucleic
acid stain (480/500 nm; Molecular Probes Inc., Eugene,
OR) using standard procedures [24,25]. Laser scanning
confocal fluorescence imaging of the biofilms was per-
formed using a Leica TCS SP1 microscope (Leica
Lasertechnik, GmbH, and Heidelberg, Germany)
equipped with argon-ion and helium neon lasers tuned to
488 and 633 nm, respectively. Triple dichroic (488/543/
633) and emission filters (Chroma Technology Corp.,
Rockingham, VT) were selected for detection of Alexa
Fluor® 647 and SYTO® 9. Confocal images were acquired
using a 40×, 0.8 numerical aperture water-immersion
objective lens, which provided an optical section thick-
ness of approximately 1 μm. Each biofilm was scanned at
5 randomly selected positions, and z series were generated
by optical sectioning at each of these positions. Images
were constructed from a 512 × 512 array of pixels span-
ning a 250 μm field of view (FOV).
Image analysis
Three independent biofilm experiments were performed
and 5 image stacks (512 × 512 pixel tagged image file for-
mat) per experiment were collected [23]. The biofilm
structure was quantified from the confocal stacks by the
image-processing software COMSTAT [26]. For this study,
biovolume and area occupied by bacteria and polysaccha-
rides in each layer were utilized to determine the differ-
ences among biofilms treated with the various test agents
and control. The biovolume is defined as the volume of
the biomass (μm3) divided by substratum (HA surface)
area (μm2). The area occupied by bacteria and polysaccha-
rides in each layer indicates the fraction (in percentage) of
the area occupied by either components in each image of
a stack, and provides the vertical distribution of each of
the biofilm components (from deeper to outer regions of
the biofilm. The three-dimensional architecture of the
biofilms was visualized using Amira™ 4.1.1 (Mercury
Computer Systems Inc., Chelmsford, MS, USA).BMC Microbiology 2009, 9:228 http://www.biomedcentral.com/1471-2180/9/228
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Biochemical analyses
The biochemical composition of the biofilms (118-h)
were also determined [21,27]. The biofilms were removed
and subjected to sonication using three 30-s pulses at an
output of 7 W (Branson Sonifier 150; Branson Ultrason-
ics, Danbury, CT) [27]. The homogenized suspension was
analyzed for dry-weight, total protein (by acid digestion
followed by ninhydrin assay; [28]) and polysaccharide
composition. The extracellular water soluble and insolu-
ble glucans, and intracellular iodophilic polysaccharides
were extracted and quantified by colorimetric assays as
detailed by Koo et al. [21].
Furthermore, F-ATPase activity of the treated biofilms was
measured according to Belli et al. [29]. Briefly, the homog-
enized suspension was permeabilized by subjecting the
biofilm cells to 10% toluene (v/v) followed by two cycles
of freezing and thawing. F-ATPase activity was measured
in terms of the release of phosphate in the following reac-
tion mixture: 75.0 mmol of Tris-maleate buffer (pH 7.0)
containing 5.0 mM ATP, 10.0 mmol MgCl2 and permeabi-
lized biofilm cells. The released phosphate (over the 10-
min reaction time) was determined by the method of Ben-
cini et al. [30].
Statistical analyses
The data were analyzed by analysis of variance (ANOVA)
in the Tukey-Kramer Honest Standard Deviation (HSD)
test for all pairs. Statistical software JMP version 3.1 (SAS
Institute, Cary, NC, USA) was used to perform the analy-
ses. The level of significance was set at 5%.
Results
Gene expression profile of S. mutans biofilms after 
treatments
The expression profile of gtfB, gtfC and gtfD (genes associ-
ated with EPS-matrix synthesis), and aguD and atpD (asso-
ciated with acid-tolerance) in S. mutans biofilms treated
with the test agents was determined at two distinct time
points (49-h and 97-h) (Figure 1). These two time points
represent the early and late stages of biofilm development
using our model [[23]; Xiao and Koo, unpublished data].
At 49-h of biofilm development (Figure 1-A), the expres-
sion of gtfB  in MFar125F-treated biofilms was signifi-
cantly decreased when compared to vehicle-treated
biofilms (p < 0.05); the expression of other gtf genes was
unaffected (p > 0.05). At 97-h (Figure 1-B), the combina-
tion of agents repressed the expression of gtfB  (by
Real-time PCR analysis of gtfB, gtfD and aguD gene expression by S. mutans treated with the test agents Figure 1
Real-time PCR analysis of gtfB, gtfD and aguD gene expression by S. mutans treated with the test agents. A) 
Biofilms 49-h old; B) 97-h old. The mRNA level of each gene in each sample was normalized to that of 16S rRNA. These 
values were then compared to those from vehicle-treated biofilms (V) (corresponding to an arbitrary value of 1) to determine 
the change (n-fold) in gene expression. Data are expressed as means ± standard deviations of triplicates from at least three 
separate experiments; values marked with an asterisk are significantly different from that for the vehicle-treated biofilms (p < 
0.05, ANOVA, comparison for all pairs using Tukey test).
A) Biofilms 49-h old
B) Biofilms 97-h old
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MFar125F and MFar250F) and gtfD (MFar250F), but not
gtfC (data not shown). The expression of aguD was signif-
icantly reduced by all treatments compared to vehicle-
control group at both time points (p < 0.05); the expres-
sion of atpD was unaffected (p > 0.05). The transcriptional
responses of S. mutans to the agents during the course of
biofilm development may affect the structural organiza-
tion and biochemical composition of the biofilms after
treatments, which were examined as follows.
Influences of treatments on structural organization and 
composition of S. mutans biofilms in vitro
LSCFM imaging and COMSTAT analysis of biofilm constituents
In this study, we determined the biovolume (biomass)
and the spatial distribution of extracellular polysaccha-
rides (EPS) and bacterial cells in the biofilms. Our confo-
cal microscopy imaging approach allows for
simultaneous quantification and visualization of bacterial
cells and EPS, which provide a more precise examination
of the biofilm architecture than labeling bacteria alone.
The biovolumes of EPS and bacterial cells of the biofilms
treated with combinations of myricetin and tt-farnesol
with 125 or 250 ppm fluoride (MFar125F and MFar250F)
were significantly lower than those of biofilms treated
with fluoride alone (250F) or vehicle-control (p < 0.05;
Table 1).
The vertical distribution of EPS and bacteria from disc sur-
face to fluid phase was also calculated from the three-
dimensional confocal imaging data sets as explained in
the schematic diagram in Figure 2. Figure 3(A-D) shows
the distribution of both EPS and bacterial cells in the bio-
films after treatments. The biofilms treated with the com-
bination of agents exhibited less EPS and bacteria across
the biofilm depth, especially in the middle (20 to 40 μm
from substratum) and outer layers (above 40 μm), than
those treated with 250F or vehicle-control. Furthermore, a
representative three-dimensional rendering of bacteria (in
green) and EPS (in red) in each of the treated biofilms are
shown in Figure 3(A1-D1). Treatments with the combina-
tion of agents resulted in biofilms displaying markedly
distinctive structure-architecture, which were less compact
and less dense (Figure 3A1, and 3C1) compared to those
treated with vehicle-control or 250F (Figure 3B1 and
3D1).
Biofilm composition analysis of the treated biofilms
Topical applications of combinations of agents resulted in
biofilms with significantly less biomass (dry-weight), and
total amounts of extracellular insoluble glucans and intra-
cellular (IPS) polysaccharides compared to those treated
with vehicle-control (Table 2; p < 0.05); MFar250F also
diminished the amounts of soluble glucans (vs. vehicle-
control; p < 0.05). Fluoride treatments also reduced the
dry-weight, and markedly disrupted IPS accumulation in
the biofilms (vs. vehicle-control; p < 0.05), but did not
reduce significantly the amounts of exopolysaccharides.
Interestingly, biofilms treated with combinations of
agents or 250F showed higher levels of F-ATPase activity
compared to vehicle-control treated biofilms (p < 0.05;
Table 2). Furthermore, treatments with combination of
agents or 250F also reduced acidogenicity of the biofilms
(Figure 4).
Discussion
Development of novel chemotherapeutic approaches,
other than microbiocides, that disrupt the establishment,
structure and virulence of dental biofilms could be a
promising route to prevent or reduce the pathogenesis of
oral infectious diseases such as dental caries. Currently,
fluoride in various preparations is the mainstay for caries
prevention [31]. Fluoride exerts its major effects by reduc-
ing enamel-dentine demineralization and enhancing rem-
ineralization of early caries lesions [18]. However,
fluoride, at levels found in plaque, also displays biological
effects on critical virulence factors of cariogenic strepto-
cocci, particularly (albeit not exclusively) on S. mutans
[10]. Nevertheless, as currently used, fluoride offers
incomplete protection against dental caries (18). Thus,
any agent that enhances its protective effects clearly has
clinical potential. Recently, we have identified specific fla-
vonoids (myricetin) and terpenoids (tt-farnesol) that
exhibit bioactivity against S. mutans; these compounds are
Table 1: Biovolume of S. mutans UA159 biofilms after treatments by COMSTAT analysis.
Treatments* MFar125F MFar250F 250F Vehicle control
Biofilm components Bacteria EPS Bacteria EPS Bacteria EPS Bacteria EPS
Biovolume 6.3 ± 1.6 A 8.8 ± 2.0 δ 5.4 ± 1.0 A 9.3 ± 0.9 δ 12.3 ± 3.5 B 13.2 ± 0.9 ε 12.0 ± 6.7 B 15.0 ± 5.7 ε
Values (SD, n = 15) in the same line for bacteria followed by the same letters are not significantly different from each other (p > 0.05, ANOVA, 
comparison for all pairs using Tukey test).
Values (SD, n = 15) in the same line for EPS followed by the same symbols are not significantly different from each other (p > 0.05, ANOVA, 
comparison for all pairs using Tukey test).
MFar125F - myricetin, tt-farnesol and 125 ppm F; MFar250F - myricetin, tt-farnesol and 250 ppm F; 250F - 250 ppm F; Vehicle control - 20% ethanol 
containing 2.5% DMSO (v/v).BMC Microbiology 2009, 9:228 http://www.biomedcentral.com/1471-2180/9/228
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ubiquitously found in fruits (cranberries and red wine
grapes) and propolis (a beehive product) [12,13,19,20].
The concentrations of 1.0 mM myricetin and 2.5 mM tt-
farnesol displayed the most potent inhibitory effects on
glucans synthesis and acid production by S. mutans cells as
determined from our published and unpublished
response to dose studies [13,19,20]. Furthermore, the
combination of the naturally occurring agents with 250
ppm fluoride was the most effective in reducing S. mutans
biofilm formation and EPS synthesis in vitro, and also
enhanced cariostatic properties of fluoride in vivo [12,13].
Analysis of our data shows that the natural agents acting
in concert with fluoride (at 125 or 250 ppm) modulated
the expression of specific virulence genes by S. mutans,
and also disrupted the accumulation and structural organ-
ization of extracellular polysaccharides (EPS) and bacte-
rial cells in the matrix, which affected the biochemical and
physiological properties of the biofilms in vitro. Although
our mono-species biofilm model does not mimic exactly
the complex microbial community found in coronal den-
tal plaque, it does however place emphasis on a critical
virulence characteristic of the biofilm, i.e. the polysaccha-
ride matrix. Furthermore, biofilms using a single organ-
ism is advantageous in examining the mechanisms of
actions of therapeutic agents on S. mutans physiology and
genetics, especially on the glucan-mediated processes
involved in the formation of the polysaccharide matrix in
biofilm.
Our in vitro data suggest at least two major mechanisms of
actions by which the combination therapy affects S.
mutans virulence: (1) inhibition of insoluble exopolysac-
charides synthesis, particular by GtfB, and (2) reduction
of intracellular polysaccharide accumulation and aci-
duricity associated with cytoplasmic acidification and
starvation stress. The combination of agents, especially
MFar125F, markedly reduced the gtfB mRNA levels in S.
mutans biofilms both at early and later stages of biofilm
development. The reduction of gtfB expression in addition
to inhibitory effects on GtfB activity (by myricetin; [19])
and enzyme production-secretion (by fluoride and tt-far-
nesol; [16,21]) appear to be one of the main pathways in
altering the accumulation and structure of biofilms. We
have shown previously that brief exposure (one-minute)
of biofilms to 2.5 mM tt-farnesol and 1 mM myricetin had
negligible effects on the vitality of S. mutans in biofilms
(compared to either vehicle treated or untreated biofilms)
[12,13,21]. In this study, the combinations of agents with
fluoride were devoid of any significant bactericidal activ-
ity against biofilms under our experimental conditions.
GtfB secreted by S. mutans not only binds to the apatitic
surface, but also on the bacterial surface in an active form
[8], which are advantageous to the organisms for the per-
sistent colonization of tooth surfaces [3]. The disruption
of insoluble glucans synthesis in situ would contribute to
(i) the overall decrease of the exopolysaccharide content
and bacterial biomass, and (ii) may explain lower EPS
biovolume within the biofilms' matrix after treatments
with the combination therapies. Biofilms containing
lower amounts of insoluble glucans across the depth of
the biofilms could influence the pathogenesis by disrupt-
ing physical integrity and stability [32], affecting the diffu-
sion properties [33], and reducing the binding sites for
mutans streptococci and lactobacilli [3,8]. The altered tri-
dimensional structure-architecture containing less insolu-
ble-glucans may also be more susceptible to inimical
Schematic diagram of determination of vertical distribution of bacteria or EPS from LSCFM imaging data by COMSTAT Figure 2
Schematic diagram of determination of vertical distribution of bacteria or EPS from LSCFM imaging data by 
COMSTAT. (A) highlight of an optical section of specific area of the biofilm; (B) COMSTAT calculate the percentage of area 
occupied by bacteria or EPS on each optical section individually (as highlighted); (C) Then, the data of each optical section is 
plotted in a graph.BMC Microbiology 2009, 9:228 http://www.biomedcentral.com/1471-2180/9/228
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influences of antimicrobials and other environmental
assaults [34].
Furthermore, gtfB  gene is a recognized virulence factor
associated with the pathogenesis of dental caries in
rodents [35]; mutant strains of S. mutans defective in gtfB
are far less cariogenic than parent strains in vivo, particu-
larly on smooth-surface caries [35]. Higher content of
insoluble glucans in the matrix is associated with
increased cariogenicity of biofilms in humans [36]. A
recent study showed that GtfB levels in saliva correlated
with presence of clinical caries in humans [37]. Thus, the
combination therapy would result in a less virulent (cari-
ogenic) biofilm. In addition, the expression of gtfD was
also repressed by MFar250F in the biofilms at later stages
of development (97-h-old); the soluble glucans produced
by GtfD can serve as primer for insoluble glucan synthesis,
and can be metabolized into acids by S. mutans [3,35],
which are additional routes for expression of virulence by
this bacterium. Further studies using functional genomics
approaches shall elucidate the exact mechanisms by
which the combination of agents affects the transcription
of these critical genes.
Concomitantly, marked reductions in IPS accumulation
and enhanced F-ATPase activity along with repression of
aguD  gene expression may indicate disruption of ΔpH
across the cell membrane and energy starvation [21] in the
(A-D) Profile of the distribution of bacteria and EPS in each of the biofilms after treatments (n = 15); (A1-D1) Representative  3-D image of the structural organization of the treated-biofilms Figure 3
(A-D) Profile of the distribution of bacteria and EPS in each of the biofilms after treatments (n = 15); (A1-D1) 
Representative 3-D image of the structural organization of the treated-biofilms. Bacteria (green) and EPS (red).
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biofilms-cells treated with the test agents. Aciduric bacte-
ria such as the mutans streptococci can carry out glycolysis
at low pH values within the biofilm's matrix even though
glycolytic enzymes are not acid tolerant, because the bac-
teria maintain ΔpH across the cell membrane with the
interior more alkaline than the exterior. During glycolysis,
protons are moved out of the cell through the proton-
translocating, membrane F-ATPase.
Fluoride short circuits this flow through the diffusion of
HF into cell, which acidifies the cytoplasm, inhibits intra-
cellular enzymes and greatly reduces the ATP-pools in bio-
film-cells [10,16]. By increasing re-entry of protons across
the cell membrane, it increases the demand on ATP that is
used by F-ATPase to pump-out protons for acid-base reg-
ulation compromising the energy status of the cell
[10,16].  tt-Farnesol and myricetin also contributes to
these effects by increasing proton permeability, and inhib-
iting glycolytic activity [19,21] enhancing the starvation
and acid sensitization of the biofilms. Moreover, the
repression of aguD expression, an important component
of the agmatine deiminase system (AgDS), by the agents
may augment the starvation stress. AgDS system converts
agmatine to putrescine, ammonia and CO2; the produc-
tion of ammonia from agmatine contributes in increasing
the cytoplasmic pH and generating ATP that can be used
for growth or to extrude protons [38].
Thus, the net result would be cytoplasmic acidification
and diminished ATP pools, and thereby disruption of IPS
Table 2: Biomass (dry-weight) and polysaccharides composition in S. mutans UA159 biofilms after treatments.
Treatments* Dry-weight (mg) Polysaccharides F-ATPase activity**
Insoluble ( g) Soluble ( g) IPS ( g)
MFar125F 3.22 ± 0.68 A 0.92 ± 0.33 A 0.24 ± 0.05 A, B 0.17 ± 0.02 A 0.94 ± 0.30 A
MFar250F 3.37 ± 0.55 A 0.98 ± 0.20 A, B 0.22 ± 0.06 A 0.15 ± 0.03 A 1.04 ± 0.27 A
250F 4.50 ± 0.48 B 1.33 ± 0.23 B, C 0.24 ± 0.08 A, B 0.18 ± 0.03 A 0.94 ± 0.19 A
Vehicle control 5.90 ± 0.80 C 1.70 ± 0.25 C 0.30 ± 0.04 B 0.47 ± 0.06 B 0.52 ± 0.08 B
Values (SD, n = 12) in the same column followed by the same letters are not significantly different from each other (p > 0.05, ANOVA, comparison 
for all pairs using Tukey test).
IPS -- Iodophilic intracellular polysaccharides
* MFar125F - myricetin, tt-farnesol and 125 ppm F; MFar250F - myricetin, tt-farnesol and 250 ppm F; 250F - 250 ppm F; Vehicle control - 20% 
ethanol containing 2.5% DMSO (v/v).
** Expressed as μg of phosphate released/mg of protein
Influence of treatments on the pH values in the culture medium during S. mutans biofilm formation Figure 4
Influence of treatments on the pH values in the culture medium during S. mutans biofilm formation. The 
medium was replaced daily with fresh medium. The pH values (n = 9) were determined at 0 h and after 4, 8, 10 and 24 h of 
incubation each day. Values from vehicle control are significantly different from MFar250 at 10 h and 24 h of incubation, and 
from all treatments at 24 h of incubation during the entire experimental period (P < 0.05, ANOVA, comparison for all pairs 
using Tukey's test).
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synthesis and acid-tolerance by S. mutans within biofilms.
The IPS, a glycogen-like storage polymer, provide S.
mutans with an endogenous source of carbohydrate which
can be metabolized when exogenous fermentable sub-
strate have been depleted in the oral cavity; as a result, IPS
can promote the formation of dental caries in animals and
in humans by prolonging the exposure of tooth surfaces
to organic acids and a concomitant lower fasting pH in the
matrix of the plaque [39-41]. Clearly, the combined
effects of the agents affected acidurance (and acid produc-
tion) of the biofilms as indicated by higher final pH val-
ues of the surrounding medium when compared to
control group, particularly MFarF250 treatments. It is
noteworthy that agents that act to restrict ATP supply to
anabolism and to maintain ΔpH would also affect protein
synthesis-secretion and gene expression.
The overall biological effects of the combination therapy,
particularly on EPS and IPS synthesis, could affect dramat-
ically the ability of S. mutans to colonize on the tooth sur-
faces and become dominant and express virulence in
plaque without necessarily killing the target organism or
disrupting the resident flora. This observation is congru-
ent with our previous findings showing effective cario-
static activity of combination of agents without
influencing the microbial composition of the animals'
plaque in a rat model of dental caries [12,13], which is de
facto an in vivo multispecies system.
It is noteworthy that the combination of natural agents
with lower concentration of fluoride (125 ppmF) was
highly effective in disrupting biofilms and expression of
gtfB, which is an indication that may affect caries develop-
ment in vivo. Interestingly, MFar125F was more effective
in reducing gtfB expression than MFar250F, which could
also explain the lower amounts of EPS in the inner layers
of the biofilms treated with MFar125F (vs. MFar250F).
Additional studies using microarrays shall determine if
other genes associated with gtfB regulation are differen-
tially affected between MFar125F or MFar250F treat-
ments, and thereby assist us in elucidating the
mechanistic basis for the phenomenon observed in this
study. At the same time, we are also investigating whether
the combination of agents may result in preparations with
lower concentrations of fluoride without reducing the car-
iostatic effectiveness.
Conclusion
The combined actions of the natural agents and fluoride
on (i) production of specific bacterial-derived GtfB glu-
cans and acidogenicity at transcriptional and physiologi-
cal levels, in addition to (ii) the physico-chemical effects
of fluoride may explain the superior cariostatic effect in
vivo of the combination therapy compared to 250 ppm
fluoride or CHX [12,13], which are proven anti-caries/
anti-plaque chemical modalities. Further studies using
multispecies biofilm models shall elucidate the biological
effects of the combination therapy on complex ecological
interactions and their influences in the EPS-matrix devel-
opment, which will advance our understanding of the
exact mechanisms of action of these agents.
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